LU75230A1 - - Google Patents

Info

Publication number
LU75230A1
LU75230A1 LU75230A LU75230A LU75230A1 LU 75230 A1 LU75230 A1 LU 75230A1 LU 75230 A LU75230 A LU 75230A LU 75230 A LU75230 A LU 75230A LU 75230 A1 LU75230 A1 LU 75230A1
Authority
LU
Luxembourg
Application number
LU75230A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of LU75230A1 publication Critical patent/LU75230A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
LU75230A 1975-06-27 1976-06-24 LU75230A1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7520241A FR2315274A1 (fr) 1975-06-27 1975-06-27 Nouveaux derives de la thieno (2,3-c) pyridine, leur preparation et leurs applications

Publications (1)

Publication Number Publication Date
LU75230A1 true LU75230A1 (en:Method) 1977-02-18

Family

ID=9157178

Family Applications (1)

Application Number Title Priority Date Filing Date
LU75230A LU75230A1 (en:Method) 1975-06-27 1976-06-24

Country Status (26)

Country Link
US (1) US4075340A (en:Method)
JP (1) JPS607633B2 (en:Method)
AR (1) AR211777A1 (en:Method)
AT (1) AT347950B (en:Method)
BE (1) BE843402A (en:Method)
CA (1) CA1071635A (en:Method)
CH (1) CH596169A5 (en:Method)
DD (1) DD125080A5 (en:Method)
DE (1) DE2628045A1 (en:Method)
DK (1) DK279976A (en:Method)
ES (1) ES449191A1 (en:Method)
FR (1) FR2315274A1 (en:Method)
GB (1) GB1492239A (en:Method)
GR (1) GR60042B (en:Method)
HU (1) HU172697B (en:Method)
IE (1) IE43915B1 (en:Method)
IL (1) IL49702A (en:Method)
LU (1) LU75230A1 (en:Method)
MX (1) MX3565E (en:Method)
NL (1) NL183032C (en:Method)
PL (1) PL105962B1 (en:Method)
PT (1) PT65271B (en:Method)
SE (1) SE421698B (en:Method)
SU (1) SU628820A3 (en:Method)
YU (1) YU39480B (en:Method)
ZA (1) ZA763270B (en:Method)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4127580A (en) * 1975-02-07 1978-11-28 Parcor Process for the preparation of thieno-pyridine derivatives
FR2395271A1 (fr) * 1977-06-21 1979-01-19 Parcor Procede de preparation de thieno (2,3-c) et thieno (3,2-c) pyridines
US4749692A (en) * 1977-06-22 1988-06-07 Sanofi, S.A. Therapeutic compositions having anti-thrombotic and anti-blood-platelet-aggregating activity
GB2038625B (en) * 1978-12-29 1983-01-12 Parcor Therapeutic composition having an antithrombotic and antiblood-platelet-aggregating activity
FR2397417A1 (fr) * 1977-07-12 1979-02-09 Parcor Procede de preparation de derives de la thienopyridine
AT368504B (de) * 1977-10-15 1982-10-25 Boehringer Sohn Ingelheim Verfahren zur herstellung neuer 4-phenyl-thieno- (2,3-c)-piperidine
US4321266A (en) * 1980-10-06 1982-03-23 Sanofi 5-o-Cyanobenzyl-4,5,6,7-tetrahydrothieno [3,2-C] pyridine
FR2508453A1 (fr) * 1981-06-30 1982-12-31 Sanofi Sa Procede de preparation de derives des (thienyl-2)- et thienyl-3)-2 ethylamines et produits ainsi obtenus
US4547514A (en) * 1983-12-05 1985-10-15 A. H. Robins Company, Incorporated Aryloxy-N-(aminoalkyl)-1-pyrrolidine and piperidine carboxamides and carbothioamides having antiarrhythmic activity
DE3736664A1 (de) * 1987-10-29 1989-05-11 Boehringer Ingelheim Kg Tetrahydro-furo- und -thieno(2,3-c)pyridine, ihre verwendung als arzneimittel und verfahren zu ihrer herstellung
US5294621A (en) * 1992-10-07 1994-03-15 Ortho Pharmaceutical Corporation Thieno tetrahydropyridines useful as class III antiarrhythmic agents
AU4698299A (en) 1998-06-30 2000-01-17 Du Pont Pharmaceuticals Company 5-HT7 receptor antagonists
AU5154699A (en) * 1998-09-02 2000-03-27 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-c)pyridine derivatives
US6090797A (en) * 1998-09-02 2000-07-18 Novo Nordisk A/S 4,5,6,7-tetrahydro-thieno(2,3-C)pyridine derivatives
US8914114B2 (en) 2000-05-23 2014-12-16 The Feinstein Institute For Medical Research Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US20040048795A1 (en) * 2002-02-26 2004-03-11 North Shore-Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by stimulation of brain muscarinic receptors
US10912712B2 (en) 2004-03-25 2021-02-09 The Feinstein Institutes For Medical Research Treatment of bleeding by non-invasive stimulation
CA2560756A1 (en) 2004-03-25 2005-10-06 The Feinstein Institute For Medical Research Methods and devices for reducing bleed time using vagus nerve stimulation
US11207518B2 (en) 2004-12-27 2021-12-28 The Feinstein Institutes For Medical Research Treating inflammatory disorders by stimulation of the cholinergic anti-inflammatory pathway
EP2298410B1 (en) 2004-12-27 2013-10-09 The Feinstein Institute for Medical Research Treating inflammatory disorders by electrical vagus nerve stimulation
US8391970B2 (en) 2007-08-27 2013-03-05 The Feinstein Institute For Medical Research Devices and methods for inhibiting granulocyte activation by neural stimulation
US9662490B2 (en) 2008-03-31 2017-05-30 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation and administration of an anti-inflammatory drug
WO2009146030A1 (en) 2008-03-31 2009-12-03 The Feinstein Institute For Medical Research Methods and systems for reducing inflammation by neuromodulation of t-cell activity
ES2452484T3 (es) 2008-11-18 2014-04-01 Setpoint Medical Corporation Dispositivos para optimizar la colocación de electrodos para la estimulación antiinflamatoria
US8996116B2 (en) 2009-10-30 2015-03-31 Setpoint Medical Corporation Modulation of the cholinergic anti-inflammatory pathway to treat pain or addiction
US9211410B2 (en) 2009-05-01 2015-12-15 Setpoint Medical Corporation Extremely low duty-cycle activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
CN102573986B (zh) 2009-06-09 2016-01-20 赛博恩特医疗器械公司 用于无导线刺激器的具有袋部的神经封套
US11051744B2 (en) 2009-11-17 2021-07-06 Setpoint Medical Corporation Closed-loop vagus nerve stimulation
US9833621B2 (en) 2011-09-23 2017-12-05 Setpoint Medical Corporation Modulation of sirtuins by vagus nerve stimulation
WO2011079309A2 (en) 2009-12-23 2011-06-30 Setpoint Medical Corporation Neural stimulation devices and systems for treatment of chronic inflammation
EP2707094B1 (en) 2011-05-09 2016-02-03 Setpoint Medical Corporation Single-pulse activation of the cholinergic anti-inflammatory pathway to treat chronic inflammation
US12172017B2 (en) 2011-05-09 2024-12-24 Setpoint Medical Corporation Vagus nerve stimulation to treat neurodegenerative disorders
JP6117334B2 (ja) 2012-03-23 2017-04-19 メモリアル スローン−ケタリング キャンサー センター 膵臓癌および関連するがんの５−アシル−６，７−ジヒドロチエノ［３，２−ｃ］ピリジンでの処置
US9572983B2 (en) 2012-03-26 2017-02-21 Setpoint Medical Corporation Devices and methods for modulation of bone erosion
WO2016018701A1 (en) * 2014-07-28 2016-02-04 Merck Sharp & Dohme Corp. FACTOR XIa INHIBITORS
US11311725B2 (en) 2014-10-24 2022-04-26 Setpoint Medical Corporation Systems and methods for stimulating and/or monitoring loci in the brain to treat inflammation and to enhance vagus nerve stimulation
WO2016126807A1 (en) 2015-02-03 2016-08-11 Setpoint Medical Corporation Apparatus and method for reminding, prompting, or alerting a patient with an implanted stimulator
US10596367B2 (en) 2016-01-13 2020-03-24 Setpoint Medical Corporation Systems and methods for establishing a nerve block
EP3405107B1 (en) 2016-01-20 2023-04-12 Setpoint Medical Corporation Control of vagal stimulation
US11471681B2 (en) 2016-01-20 2022-10-18 Setpoint Medical Corporation Batteryless implantable microstimulators
EP3405255A4 (en) 2016-01-20 2019-10-16 Setpoint Medical Corporation IMPLANTABLE MICROSTIMULATORS AND INDUCTIVE CHARGING SYSTEMS
US10583304B2 (en) 2016-01-25 2020-03-10 Setpoint Medical Corporation Implantable neurostimulator having power control and thermal regulation and methods of use
US11173307B2 (en) 2017-08-14 2021-11-16 Setpoint Medical Corporation Vagus nerve stimulation pre-screening test
US11260229B2 (en) 2018-09-25 2022-03-01 The Feinstein Institutes For Medical Research Methods and apparatuses for reducing bleeding via coordinated trigeminal and vagal nerve stimulation
CN113939334A (zh) 2019-04-12 2022-01-14 赛博恩特医疗器械公司 迷走神经刺激来处理神经退行性障碍
KR20230012585A (ko) 2020-05-21 2023-01-26 더 파인스타인 인스티튜츠 포 메디칼 리서치 미주 신경 자극을 위한 시스템들 및 방법들
US12444497B2 (en) 2021-05-17 2025-10-14 Setpoint Medical Corporation Neurostimulation parameter authentication and expiration system for neurostimulation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2215948B1 (en:Method) * 1973-02-01 1976-05-14 Centre Etd Ind Pharma

Also Published As

Publication number Publication date
JPS525793A (en) 1977-01-17
AT347950B (de) 1979-01-25
CH596169A5 (en:Method) 1978-02-28
NL183032B (nl) 1988-02-01
ZA763270B (en) 1977-05-25
GR60042B (en) 1978-04-01
FR2315274A1 (fr) 1977-01-21
AU1537576A (en) 1978-01-05
BE843402A (fr) 1976-12-27
FR2315274B1 (en:Method) 1979-08-10
US4075340A (en) 1978-02-21
PT65271B (fr) 1977-12-10
GB1492239A (en) 1977-11-16
ATA461776A (de) 1978-06-15
IE43915L (en) 1976-12-27
JPS607633B2 (ja) 1985-02-26
PL105962B1 (pl) 1979-11-30
AR211777A1 (es) 1978-03-15
NL183032C (nl) 1988-07-01
MX3565E (es) 1981-03-13
PT65271A (fr) 1976-07-01
SE421698B (sv) 1982-01-25
SE7607201L (sv) 1976-12-28
SU628820A3 (ru) 1978-10-15
YU39480B (en) 1984-12-31
DD125080A5 (en:Method) 1977-03-30
CA1071635A (en) 1980-02-12
YU146276A (en) 1982-05-31
IL49702A (en) 1979-01-31
DK279976A (da) 1976-12-28
HU172697B (hu) 1978-11-28
IL49702A0 (en) 1976-08-31
NL7606574A (nl) 1976-12-29
IE43915B1 (en) 1981-07-01
DE2628045A1 (de) 1977-01-20
ES449191A1 (es) 1977-12-01

Similar Documents

Publication Publication Date Title
JPS5434677B2 (en:Method)
CH599661A5 (en:Method)
CH594241A5 (en:Method)
BE836973A (en:Method)
BE842510A (en:Method)
BG21166A1 (en:Method)
BG21518A1 (en:Method)
BG21916A1 (en:Method)
BG22676A1 (en:Method)
BG22932A1 (en:Method)
BG23194A1 (en:Method)
BG23350A1 (en:Method)
CH284975A4 (en:Method)
CH581299A5 (en:Method)
CH583429A5 (en:Method)
CH583937A5 (en:Method)
CH587738A5 (en:Method)
CH588797A5 (en:Method)
CH589307A5 (en:Method)
CH590465A5 (en:Method)
CH590731A5 (en:Method)
CH590952A5 (en:Method)
CH590960B5 (en:Method)
CH591012A5 (en:Method)
CH592213A5 (en:Method)

Legal Events

Date Code Title Description
DT Application date
TA Annual fee